- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BMY
Recent news which mentions BMY
10 Health Care Stocks Whale Activity In Today's Session
April 07, 2023
From Benzinga
2 Ultra-Cheap Dividend Stocks to Buy in April
April 04, 2023
From Motley Fool
Bristol Myers' Flagship Opdivo Shows Long Term Durable Benefits In Lung Cancer Patients
March 30, 2023
Tickers
BMY
From Benzinga
From Benzinga
AbbVie Walks Away From CytomX Partnership, But Garnering Attention Of Big Pharma Partners
March 28, 2023
From Benzinga
From Motley Fool
From Motley Fool
From Benzinga
Takeda's Highest Dose Psoriasis Candidate Can Potentially Beat Bristol Myers' Approved Drug, Analyst Says
March 20, 2023
From Benzinga
Wall Street Is Bullish on GE HealthCare as It Invests in AI
March 20, 2023
From Motley Fool
4 Top Value Stock ETFs for Long-Term Wealth Building
March 19, 2023
From Motley Fool
2 Top Healthcare Stocks to Buy for the Long Haul
March 17, 2023
From Motley Fool
Buffett loves cash dividends and here’s why you should too – plus 8 stocks with higher yield to get you started.
March 16, 2023
From MarketWatch
From Motley Fool
Best-Selling Drugs by Bristol Myers, Pfizer, AbbVie Likely Candidates For US Price Negotiation
March 13, 2023
From Benzinga
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
March 07, 2023
From Benzinga
Quant Ratings Updated on 157 Stocks
March 07, 2023
From InvestorPlace
From Benzinga
7 Dividend Stocks to Buy During a Market Downturn
February 27, 2023
From InvestorPlace
Why Nektar Therapeutics Stock Is Plunging Today
February 24, 2023
From Benzinga
This Recession-Proof Company Has a Best-in-Class Dividend
February 22, 2023
From Motley Fool
3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later
February 18, 2023
From Motley Fool
I ‘Tricked’ ChatGPT Into Picking Stocks to Buy. Here’s What It Said.
February 17, 2023
From InvestorPlace
Bristol Myers' Opdivo Shows Improved Clinical Benefits In Bladder Cancer At Three Years
February 17, 2023
Tickers
BMY
From Benzinga
Bristol Myers Squibb-Exelixis Highlight Three-Year Follow Up Data From Opdivo+Cabometyx Combo Therapy In Kidney Cancer
February 14, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.